PCSK1N and liver cancer: Specifically, a high ratio of SAAs+ hepatocytes in the invasive zone was significantly correlated with a worse OS in patients with primary (P < 0.01) and secondary liver cancer (P < 0.05) (validation cohort 4; Fig. 6d; Supplementary information, Fig. S10c).